Blood Loss, Postoperative Clinical Trial
Official title:
The Risk Factors for Perioperative Blood Transfusion in Open Liver Resection, a Retrospective Cohort Study Development of a Transfusion Scoring System to Predict the Requirement for Perioperative Blood Transfusion in Open Liver Resection
Verified date | February 2024 |
Source | Chiang Mai University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This observational study is specifically designed to identify the pre-operative risk factors that significantly contribute to perioperative packed red cell transfusions in open liver resection procedures. The main question it aims to answer are: 1. What are the risk factors of peri-operative blood transfusion in open liver resection procedures 2. What are the difference outcomes between patients who receive blood transfusion and the other group. Researcher will compare perioperative factor and post operative outcomes between transfused and non-transfused group
Status | Completed |
Enrollment | 1201 |
Est. completion date | January 1, 2023 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - All genders age above 18 year old who underwent open liver resection from 2006-2017 - Elective open liver resection Exclusion Criteria: - Patients who death during the course of a surgical operation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Chiang Mai University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | the pre-operative risk factors of perioperative packed red cell transfusions in open liver resection procedures. | Significant risk factors for perioperative blood transfusion were determined by factors with a p-value < 0.05 derived from the multivariable logistic regression analysis. This analysis facilitated adjustments for potential confounders to identify the independent risk factors associated with perioperative blood transfusion | the transfusion of packed red cells during the operation and 48 hours after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05077124 -
Safe and Timely Antithrombotic Removal (STAR) Registry
|
||
Completed |
NCT03622671 -
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
|
N/A | |
Not yet recruiting |
NCT06060327 -
Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section
|
N/A | |
Completed |
NCT02509312 -
Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery
|
Phase 4 | |
Recruiting |
NCT05316649 -
Blood Loss Quantification During Major Abdominal Surgery
|
||
Completed |
NCT03967171 -
The Comparison of the Effect of Different Oxytocin Administrations on the Blood Loss During Cesarean Delivery
|
N/A | |
Completed |
NCT05273632 -
Comparison Study of Oxytocin Versus Tranexamic Acid and Etamsylaye Versus Placebo(Saline)
|
N/A | |
Completed |
NCT05204056 -
Application of Iced Normal Saline Combined With Cocktail Perfusion in Total Knee Arthroplasty
|
N/A | |
Active, not recruiting |
NCT03805607 -
IV Ketorolac on Platelet Function Post-Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03249038 -
Estimated Blood Loss: Novel Model for Estimating Surgical Blood Loss.
|
N/A | |
Terminated |
NCT05093504 -
Safe and Timely Antithrombotic Removal - Direct Oral Anticoagulants Apixaban & Rivaroxaban (STAR-D)
|
N/A | |
Recruiting |
NCT06049160 -
Comparative Study Between Preoperative and Postoperative Rectal Misoprostol
|
N/A | |
Completed |
NCT04976530 -
Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
|
N/A | |
Completed |
NCT03555383 -
Individualized Multimodal Hemostasis Evaluation Pyramid (IMHOTEP)
|
||
Active, not recruiting |
NCT02438566 -
Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery
|
Phase 3 | |
Completed |
NCT04656067 -
Comparative Study Between Oxytocin Versus Tranexamic Acid and Ethamsylate
|
Phase 1/Phase 2 |